id='420d1b09-0617-47c1-bff5-02b1fcd6bd8a' embedding=None sparse_embedding=None metadata={'document': 'Patients with a clinically significant result on tuberculin skin testing or a positive interferon-gamma release assay (IGRA) result should receive a course of therapy for latent TB once active infection and disease are ruled out. Recommended regimens for latent TB published by the US Centers for Disease Control and Prevention (CDC) are as follows [12, 16] :\n\nIsoniazid 300 mg - Daily for 9 months\n\nIsoniazid 900 mg - Twice weekly for 9 months (administered as DOT)\n\nIsoniazid 300 mg - Daily for 6 months (should not be used in patients with fibrotic lesions on chest radiography, patients with HIV infection, or children)'} document='Patients with a clinically significant result on tuberculin skin testing or a positive interferon-gamma release assay (IGRA) result should receive a course of therapy for latent TB once active infection and disease are ruled out. Recommended regimens for latent TB published by the US Centers for Disease Control and Prevention (CDC) are as follows [12, 16] :\n\nIsoniazid 300 mg - Daily for 9 months\n\nIsoniazid 900 mg - Twice weekly for 9 months (administered as DOT)\n\nIsoniazid 300 mg - Daily for 6 months (should not be used in patients with fibrotic lesions on chest radiography, patients with HIV infection, or children)' score=0.86466515
id='f1336a29-3474-4834-be52-908ce2e32c93' embedding=None sparse_embedding=None metadata={'document': "Latent TB infection.Primary infection is usually followed by the stage\ncalled latent TB infection. Immune system cells build a wall around lung\ntissue with TB germs. The germs can't do any more harm if the immune system\nkeeps them under control. But the germs survive. There are no symptoms during\nlatent TB infection."} document="Latent TB infection.Primary infection is usually followed by the stage\ncalled latent TB infection. Immune system cells build a wall around lung\ntissue with TB germs. The germs can't do any more harm if the immune system\nkeeps them under control. But the germs survive. There are no symptoms during\nlatent TB infection." score=0.86400247
id='50d5a791-08ed-4311-93fb-bbb5b0d68d10' embedding=None sparse_embedding=None metadata={'document': 'The primary screening method for tuberculosis (TB) infection (active or latent) is the Mantoux tuberculin skin test with purified protein derivative (PPD). An in vitro blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis can also screen for latent TB infection. IGRA assays offer certain advantages over tuberculin skin testing. [114, 115]\n\nObtain the following laboratory tests for patients with suspected TB:\n\nAcid-fast bacilli (AFB) smear and culture - Using sputum obtained from the patient\n\nHIV serology in all patients with TB and unknown HIV status'} document='The primary screening method for tuberculosis (TB) infection (active or latent) is the Mantoux tuberculin skin test with purified protein derivative (PPD). An in vitro blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis can also screen for latent TB infection. IGRA assays offer certain advantages over tuberculin skin testing. [114, 115]\n\nObtain the following laboratory tests for patients with suspected TB:\n\nAcid-fast bacilli (AFB) smear and culture - Using sputum obtained from the patient\n\nHIV serology in all patients with TB and unknown HIV status' score=0.85860646
id='636f170d-97ff-4ee6-ad41-a1faef6ef610' embedding=None sparse_embedding=None metadata={'document': 'The primary screening method for tuberculosis (TB) infection (active or latent) is the Mantoux tuberculin skin test with purified protein derivative (PPD). An in vitro blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis can also screen for latent TB infection. IGRA assays offer certain advantages over tuberculin skin testing. [114, 115]\n\nObtain the following laboratory tests for patients with suspected TB:\n\nAcid-fast bacilli (AFB) smear and culture - Using sputum obtained from the patient\n\nHIV serology in all patients with TB and unknown HIV status'} document='The primary screening method for tuberculosis (TB) infection (active or latent) is the Mantoux tuberculin skin test with purified protein derivative (PPD). An in vitro blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis can also screen for latent TB infection. IGRA assays offer certain advantages over tuberculin skin testing. [114, 115]\n\nObtain the following laboratory tests for patients with suspected TB:\n\nAcid-fast bacilli (AFB) smear and culture - Using sputum obtained from the patient\n\nHIV serology in all patients with TB and unknown HIV status' score=0.85860646
id='9142a25e-3b7d-46b8-8ece-3442fd0b9c74' embedding=None sparse_embedding=None metadata={'document': 'Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method)\nIn vitro, blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis for latent infection\nObtain the following laboratory tests for patients with suspected TB:'} document='Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method)\nIn vitro, blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis for latent infection\nObtain the following laboratory tests for patients with suspected TB:' score=0.8575673
id='ad0e7562-c4b1-4183-999a-fa311e569b70' embedding=None sparse_embedding=None metadata={'document': 'Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method)\nIn vitro, blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis for latent infection\nObtain the following laboratory tests for patients with suspected TB:'} document='Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method)\nIn vitro, blood test based on interferon-gamma release assay (IGRA) with antigens specific for Mycobacterium tuberculosis for latent infection\nObtain the following laboratory tests for patients with suspected TB:' score=0.8575673
id='67436b7f-cf60-4bda-9052-aed129f55bb8' embedding=None sparse_embedding=None metadata={'document': 'Treatment of Latent TB\nThe antimycobacterial rifapentine (Priftin), which was previously approved for use against active pulmonary TB caused by Mycobacterium tuberculosis, has been approved by the US Food and Drug Administration (FDA) for use, in combination with isoniazid, in the treatment of latent TB infection. Therapy was approved for patients aged 2 years or older who are at high risk for progression to TB disease. [15, 159]'} document='Treatment of Latent TB\nThe antimycobacterial rifapentine (Priftin), which was previously approved for use against active pulmonary TB caused by Mycobacterium tuberculosis, has been approved by the US Food and Drug Administration (FDA) for use, in combination with isoniazid, in the treatment of latent TB infection. Therapy was approved for patients aged 2 years or older who are at high risk for progression to TB disease. [15, 159]' score=0.844267
id='3f0099ee-856d-444d-ac44-d11a0dc79a0b' embedding=None sparse_embedding=None metadata={'document': "The disease is more likely to spread when people spend a lot of time together\nin an indoor space. So the disease spreads easily in places where people live\nor work together for long periods. Also, the disease spreads more easily in\ncrowded gatherings.\n\nA person with a latent TB infection cannot pass the disease to other people. A\nperson taking drugs to treat active TB disease usually can't pass the disease\nafter 2 to 3 weeks of treatment.\n\n    Drug-resistant TB"} document="The disease is more likely to spread when people spend a lot of time together\nin an indoor space. So the disease spreads easily in places where people live\nor work together for long periods. Also, the disease spreads more easily in\ncrowded gatherings.\n\nA person with a latent TB infection cannot pass the disease to other people. A\nperson taking drugs to treat active TB disease usually can't pass the disease\nafter 2 to 3 weeks of treatment.\n\n    Drug-resistant TB" score=0.8415687
id='4188849d-cbbb-4a40-b193-c10cdd3fcac4' embedding=None sparse_embedding=None metadata={'document': 'As part of an open-label, phase 4 randomized clinical trial, researchers enrolled 1002 patients from outpatient TB clinics in the United States, Spain, Hong Kong, and South Africa between September 2012 and April 2014. Patients with active TB, prior treatment for TB lasting more than 1 week, contact with someone with a resistant form of TB, or prior intolerance to anti-TB agents were excluded. Most enrolled patients (n=774) were in the United States; however, participants were demographically similar between groups. The median age was 36, and 48.1% of the patients were women.'} document='As part of an open-label, phase 4 randomized clinical trial, researchers enrolled 1002 patients from outpatient TB clinics in the United States, Spain, Hong Kong, and South Africa between September 2012 and April 2014. Patients with active TB, prior treatment for TB lasting more than 1 week, contact with someone with a resistant form of TB, or prior intolerance to anti-TB agents were excluded. Most enrolled patients (n=774) were in the United States; however, participants were demographically similar between groups. The median age was 36, and 48.1% of the patients were women.' score=0.8359593
id='1f6ebc92-cdab-4cce-a08e-90fc2fcd1b37' embedding=None sparse_embedding=None metadata={'document': "Prevention\n\nIf you test positive for latent TB infection, you may need to take drugs to\nprevent active TB disease.\n\n    Preventing the spread of disease\n\nIf you have active TB disease, you'll need to take steps to prevent other\npeople from getting an infection. You will take drugs for four, six or nine\nmonths. Take all of the drugs as directed during the entire time.\n\nDuring the first 2 to 3 weeks, you will be able to pass TB bacteria to others.\nProtect others with these steps:"} document="Prevention\n\nIf you test positive for latent TB infection, you may need to take drugs to\nprevent active TB disease.\n\n    Preventing the spread of disease\n\nIf you have active TB disease, you'll need to take steps to prevent other\npeople from getting an infection. You will take drugs for four, six or nine\nmonths. Take all of the drugs as directed during the entire time.\n\nDuring the first 2 to 3 weeks, you will be able to pass TB bacteria to others.\nProtect others with these steps:" score=0.8326384
